InsidersTradesSigma
Track the LongBio Pharma (Suzhou) Co., Ltd. - B - H Shares stock price and the full insider trade history of the company, a listed issuer based in Hong Kong. Shares are quoted on HK HK, under the oversight of HKEX. Market capitalisation: €11.2bn. The latest transaction was reported on 23 June 2026 (Other). Among the most active insiders: LIU Heng. Every trade is accessible without an account.
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
2 of 2 declarations
LongBio Pharma (Suzhou) Co., Ltd. is a pharmaceutical company focused on the development of biological treatments. It is listed under the B shares category in Hong Kong.